Company Filing History:
4 out of 15,471 
3 out of 3,975 
Years Active: 1988-2008
Title: Innovations of Ronald H. Jensen: Pioneering Advances in Prostate Cancer Detection
Introduction: Ronald H. Jensen, based in Livermore, California, is a notable inventor recognized for his significant contributions to medical technology. With a total of seven patents to his name, Jensen has focused his research on genetic alterations associated with prostate cancer, developing innovative solutions for early detection and diagnosis.
Latest Patents: One of Jensen's latest patents revolves around the development of new probes designed for the detection of prostate cancer cells. These advanced probes selectively bind to target polynucleotide sequences, which include regions such as 2q, 4q, 5q, 6q, 10p, 15q, 1q, 2p, 3q, 3p, 4q, 6p, 7p, 7q, 9q, 11p, 16p, and 17q. This innovative approach has the potential to significantly enhance the accuracy of prostate cancer diagnostics, providing healthcare professionals with essential tools for early intervention.
Career Highlights: Throughout his career, Ronald H. Jensen has garnered valuable experience and has made pivotal contributions while working at prestigious institutions. He has been affiliated with the University of California, leveraging his expertise in genetics and molecular biology. Additionally, he has contributed to projects for the United States government, further showcasing the impact of his inventions on national health initiatives.
Collaborations: Jensen has collaborated with prominent researchers in the field, including Michael L. Cher and Martin Vanderlaan. These collaborations have enriched his work and fostered innovation in detecting genetic alterations associated with prostate cancer, leading to advancements that aid medical professionals in diagnosis.
Conclusion: Ronald H. Jensen stands out as an inventive mind in the realm of cancer research. His dedication to developing groundbreaking detection technologies exemplifies the vital role inventors play in enhancing healthcare solutions. As the medical community continues to tackle prostate cancer, Jensen's contributions remain essential in the pursuit of effective diagnostics and treatments.